Literature DB >> 7624125

Evidence that c-myc mediated apoptosis does not require wild-type p53 during lymphomagenesis.

B Hsu1, M C Marin, A K el-Naggar, L C Stephens, S Brisbay, T J McDonnell.   

Abstract

Deregulation of c-myc, frequently implicated in oncogenesis, is associated with increased cell proliferation and also cell death. Similarly, the p53 tumor suppressor gene commonly mutated in human tumors, is known to induce apoptosis or cell cycle arrest in its wild-type conformation. Genetically altered mice simultaneously overexpressing c-myc and possessing a disrupted p53 gene were used to investigate whether c-myc mediated apoptosis requires wild-type p53. The accelerated development of malignant lymphomas in these mice was found to be a consequence of enhanced proliferation and not reduced apoptosis resulting from the synergistic effect of c-myc overexpression and p53 inactivation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7624125

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  29 in total

1.  Apoptosis triggered by Myc-induced suppression of Bcl-X(L) or Bcl-2 is bypassed during lymphomagenesis.

Authors:  C M Eischen; D Woo; M F Roussel; J L Cleveland
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

Review 2.  Cell cycle and apoptosis.

Authors:  Katrien Vermeulen; Zwi N Berneman; Dirk R Van Bockstaele
Journal:  Cell Prolif       Date:  2003-06       Impact factor: 6.831

3.  Loss of p73 promotes dissemination of Myc-induced B cell lymphomas in mice.

Authors:  Alice Nemajerova; Oleksi Petrenko; Lorenz Trümper; Gustavo Palacios; Ute M Moll
Journal:  J Clin Invest       Date:  2010-05-17       Impact factor: 14.808

4.  Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.

Authors:  C M Eischen; J D Weber; M F Roussel; C J Sherr; J L Cleveland
Journal:  Genes Dev       Date:  1999-10-15       Impact factor: 11.361

5.  INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53.

Authors:  C A Schmitt; M E McCurrach; E de Stanchina; R R Wallace-Brodeur; S W Lowe
Journal:  Genes Dev       Date:  1999-10-15       Impact factor: 11.361

6.  Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF.

Authors:  J J Jacobs; B Scheijen; J W Voncken; K Kieboom; A Berns; M van Lohuizen
Journal:  Genes Dev       Date:  1999-10-15       Impact factor: 11.361

7.  Tissue-specific and reversible RNA interference in transgenic mice.

Authors:  Ross A Dickins; Katherine McJunkin; Eva Hernando; Prem K Premsrirut; Valery Krizhanovsky; Darren J Burgess; Sang Yong Kim; Carlos Cordon-Cardo; Lars Zender; Gregory J Hannon; Scott W Lowe
Journal:  Nat Genet       Date:  2007-06-17       Impact factor: 38.330

8.  Bim is a suppressor of Myc-induced mouse B cell leukemia.

Authors:  Alexander Egle; Alan W Harris; Philippe Bouillet; Suzanne Cory
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-12       Impact factor: 11.205

9.  Moloney murine leukemia virus-induced lymphomas in p53-deficient mice: overlapping pathways in tumor development?

Authors:  E W Baxter; K Blyth; L A Donehower; E R Cameron; D E Onions; J C Neil
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

10.  p53-dependent senescence delays Emu-myc-induced B-cell lymphomagenesis.

Authors:  S M Post; A Quintás-Cardama; T Terzian; C Smith; C M Eischen; G Lozano
Journal:  Oncogene       Date:  2009-11-23       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.